investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

FOXD3 Up-Regulation and ERBB3 Signaling as an Adaptive Response to RAF Inhibitors

Andrew E Aplin

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Andrew E Aplin

Thomas Jefferson University

Philadelphia, United States

Thore Kettmann

U3 Pharma Gmbh

Martinsried, Germany

Related projects

Meenhard F Herlyn

The Role of Genetic Susceptibility in Melanoma Development

Melanoma of skin

Pathology

Malavika Raman

The Role Of p97-Chaperone Complexes In Protein Quality Control

Melanoma of skin

Pathology

Isaac Brownell

Clinical Treatment of Advanced Merkel Cell Carcinoma

Melanoma of skin

Pathology

Douglas R Green

RIPK-dependent necrosis in development and cancer

Melanoma of skin

Pathology

Anne Mary Bowcock

The Genetics of Ocular Melanoma

Melanoma of skin

Pathology

Eva Hernando

Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis

Melanoma of skin

Pathology

Elizabeth Grimm

Aberrant Silencing of a Large Micro-RNA Cluster on Chromosome 14q32 and its Relation to Aberrant c-MET/n-RAS Signaling in Cutaneous Malignant Melanoma-Implications for Novel Therapeutic Approaches and Biomarkers

Melanoma of skin

Pathology

Nicholas Mitsiades

Regulation Of Uveal Melanoma Cell Fate By The Pkc Pathway Via Mitf

Melanoma of skin

Pathology

Timothy N Bullock

BLIMP-1 Mediated Regulation of CD8+ TIL

Melanoma of skin

Pathology